This federal contract award, valued at $1,965.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024. The contract is for the delivery of TELMISARTAN-AMLODIPINE 40-5 MG 30S, a cardiovascular medication, with a completion date of December 3, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There was no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/9/25, 1:00 AM